RNAConnect, a leader in next-generation molecular biology tools, today announced the commercial launch of the UltraMarathonRT cDNA Synthesis and Amplification Kit, designed to elevate short-read RNA ...

CareDx, Inc. faces uncertainty with proposed reimbursement changes, but has long-term potential in the $8 billion transplant ...

Fintel reports that on August 26, 2025, William Blair initiated coverage of CareDx (NasdaqGM:CDNA) with a Market Perform ...

CareDx ( (CDNA)) has issued an update. CareDx announced the appointment of Nathan Smith as the new Chief Financial Officer effective August 7, 2025, following the retirement of Abhishek Jain. The ...

In addition to Craig-Hallum, CareDx also received a Buy from BTIG’s Mark Massaro in a report issued on July 28. However, on July 22, TR | OpenAI – 4o reiterated a Hold rating on CareDx (NASDAQ: CDNA).

AMD to host 2025 Financial Analyst Day this November, where it will reveal its strategic technology and products roadmaps ...

William Blair initiated coverage of CareDx (CDNA) with a Market Perform rating and no price target The firm says CareDx is a pure-play provider of ...

AMD has confirmed that its CDNA 3 architecture is the world's first exascale APU design: both CPU + GPU chiplets on single package.

Investors bullish on biotech sector should consider CDNA stock for potential growth with innovative transplant testing services and strong leadership.

A protocol for 5′ end cDNA amplification by classic RACE is presented here. 3′ end cDNA amplification can also be performed using a classic RACE protocol as described in a separate protocol 16.

Another cDNA isolated by this means showed high sequence similarity with a gene coding for a 4-hydroxyphenylpyruvate dioxygenase. The other three larger cDNA clones isolated by this procedure so far ...

Vaccination with a virus-expressed cDNA library derived from normal prostate cells can cure established prostate cancer in mouse models. Pulido et al. extend this approach and identify specific ...